These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 12570331)

  • 1. Chemoprevention strategies for prostate cancer.
    Bosland MC; McCormick DL; Melamed J; Walden PD; Zeleniuch-Jacquotte A; Lumey LH
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S18-27. PubMed ID: 12570331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of chemoprevention for prostate cancer development: experimental in vivo approaches to chemoprevention.
    Shirai T
    Pathol Int; 2008 Jan; 58(1):1-16. PubMed ID: 18067635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of prostate cancer.
    Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future status of prostate cancer chemoprevention.
    Fujimoto N; Nomura M; Matsumoto T
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):59-71. PubMed ID: 16375645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of prostate cancer chemoprevention: a decision analysis model.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of PSA as biomarker in nutritional intervention studies of prostate cancer.
    van Weerden WM; Schröder FH
    Chem Biol Interact; 2008 Jan; 171(2):204-11. PubMed ID: 18177847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tea beverage in chemoprevention and chemotherapy of prostate cancer.
    Siddiqui IA; Saleem M; Adhami VM; Asim M; Mukhtar H
    Acta Pharmacol Sin; 2007 Sep; 28(9):1392-408. PubMed ID: 17723173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tea beverage in chemoprevention of prostate cancer: a mini-review.
    Saleem M; Adhami VM; Siddiqui IA; Mukhtar H
    Nutr Cancer; 2003; 47(1):13-23. PubMed ID: 14769533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of prostate cancer.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA
    J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hormone-related cancers: prostate cancer.
    Parnes HL; Thompson IM; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of prostate cancer through dietary agents: progress and promise.
    Syed DN; Khan N; Afaq F; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2193-203. PubMed ID: 18006906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.